Archives

by in
Entry Author Date Location
New Venture Funds, Sympoz’s Big Score are Top Colorado Stories for 4Q 01/02/14 Boulder/Denver
Biodesix Closes $8.3M Round, New Clovis Shareholders Begin Selling 12/03/13 Boulder/Denver
Clovis Oncology CEO Mahaffy Opens Up About Company’s Turbulent Year 10/17/13 Boulder/Denver
Colorado Biotech Searches for a Few More Investors, Anchor Tenants 10/16/13 Boulder/Denver
Foundation Medicine Lays Groundwork For $86M IPO 07/29/13 Boston
Rally’s $84M IPO, NexGen’s $119M Exit Made Quarter One to Remember 07/01/13 Boulder/Denver
Clovis Oncology Closes $275M Offering Following Two Pivotal Weeks 06/18/13 Boulder/Denver
Clovis Oncology Boosts Public Offering to $240M After Stock Booms 06/12/13 Boulder/Denver
Clovis Oncology to Raise $170M as Stock Price Booms Following ASCO 06/10/13 Boulder/Denver
ASCO Wrap-Up: Cancer News from the East, South, & Rockies 06/05/13 National
Frazier Makes It Official: Seeking to Raise New $400M Fund 07/03/12 Seattle
Clovis Oncology Lands $130,000,000 New Financing 11/15/11 Boulder/Denver
Clovis Oncology Obtains $130,000,000 New Financing Round 11/15/11 Boulder/Denver
Groupon: The IPO With More Sizzle, and Money, Than the Entire Biotech IPO Class of 2011 11/07/11 National
Clovis Oncology Receives $20,000,000 New Round 06/03/11 Boulder/Denver
Sanofi Taps Avila Therapeutics for Covalent Cancer Drugs in Potential $800M Deal 12/20/10 Boston
Novartis Takes Aim at Bay-Area Biotech with Dana-Farber Roots in Legal Battle Over Potential Lung Cancer Drugs 12/02/10 Boston
Avila Therapeutics Pursuing Rival to Lung Cancer Drug in Dana-Farber Lawsuit 11/12/10 Boston
Stealthy Mercator, Founded by Biogen Idec Veterans, Raises $2M to Attack Cancer 08/11/10 Boston
FDA Approves Genzyme Pompe Drug, Vertex Hepatitis C Drug Trial Succeeds, Thermo Fisher Acquires Fermentas, & More Boston-Area Life Sciences News 05/28/10 Boston
Logical and Arsenal Get $10M Apiece, Constant Contact Acquires NutshellMail, Avila Gets $209M From Clovis, & More Boston-Area Deals News 05/26/10 Boston
Avila Therapeutics Strikes $209M Lung Cancer Deal with Clovis Oncology 05/25/10 Boston
Clovis Oncology Secures $65,635,000 New Financing 12/31/09 Boulder/Denver
Page 1 of 1